3D Printing Stocks

[BiotechValues]

Looks like BV has increased to $3+

$46.7m in shareholder equity on 15.4m shares = ~ $3.03

There is no preferred equity to deduct.


I wish ARCW had stuck with their business focus (as I understood it anyway) from two years ago of growing 3DMT/3D printing in part by using their existing MIM operations/contacts.

3DMT is by far the fastest growing part of the business (135% in last Q) and I believe they could have had similar growth at 3DMT without all the dilution and CAPEX that really gave EPS a hit. This is the same issue with DDD and SSYS of course, and it's not something they're going to turn around in the next Q either based on their dim outlook for fy Q1.